The Vanguard S&P 500 ETF ($VOO) rose 0.93% on Tuesday, supported by growing expectations of Federal Reserve rate cuts and ...

Pharmacies are seeing high demand for Pfizer COVID vaccine, yet many have not seen a shipment from the company in weeks, ...

C&EN networking event in New York City. Please join us if you’re in town! Here’s a link to the invitation. Questions? Comments? Tips? Let us know. Email Michael McCoy, C&EN’s executive editor for ...

In today’s Pharmaceutical Executive Daily, Novo Nordisk faces market pressure after a late-stage trial setback, Moderna takes ...

Moderately bullish activity in Moderna (MRNA), with shares up 62c, or 2.55%, near $24.77. Options volume relatively light with 58k contracts ...

An audit of the federal government’s controversial deal to bring Moderna to Melbourne to manufacture vaccines has been ...

The iShares Biotechnology ETF (NYSE: IBB) has risen for six straight months, notching its longest winning streak since 2012.

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Moderna ( (MRNA) ) just unveiled an update.